NCT04889495 2025-03-19A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerPfizerWithdrawn
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT00017537 2013-08-05Vaccine Therapy in Treating Patients With Metastatic or Recurrent CancerUniversity of Alabama at BirminghamPhase 1 Withdrawn
NCT01000896 2010-02-04Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelAstraZenecaPhase 1 Withdrawn27 enrolled